Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-09

Clinical Trial Update: Plasma Copeptin in Response to Oral Urea in Healthy Adults and Patients With Polyuria-polydipsia Syndrome [NA]

View source ↗

Summary

A completed trial assesses plasma copeptin response to oral urea in healthy adults and in patients with Arginine Vasopressin Deficiency or Primary Polydipsia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oral Urea (urea)

Snippet

Sponsor: University Hospital, Basel, Switzerland | Conditions: Arginine Vasopressin Deficiency, Primary Polydipsia | NA | Status: COMPLETED